FILTER
FILTERED INTERVIEW RESULTS
Ricardo do Amaral
GENERAL MANAGER, OCTOMAR
"2024 was a busy year, ending with four parallel operations for the first time, and over 120 diving personnel working offshore in the last quarter, all while maintaining a flawless safety record."
Simon Meadows Smith
MANAGING DIRECTOR, SEMS EXPLORATION
"SEMS has therefore focussed on providing technical services that our customers may not have in-house, such as topographic and geophysical drone services, which is a great area of growth for us."
Janice Faria
CEO, ENAGOL
"The industry is resistant to change, but we are committed to proving our capability and hope Enagol will become a leading NDT service provider."
Mario Bello
HEAD OF SUB-SAHARAN AFRICA REGION, ENI
"Today, over 50% of our hydrocarbon production and reserves come from Africa, and we plan to allocate over 50% of our upstream CapEx here in the future."
Paula Dantas
MANAGING PARTNER, PROMETIM
"The ANPG could advocate for major industry players to allocate portions of large contracts to local companies, thereby fostering their development and integration into the broader industry ecosystem."
NJ Ayuk
EXECUTIVE CHAIRMAN, AFRICAN ENERGY CHAMBER
"We are combating the demonization of natural gas usage, emphasizing Africa's right to utilize it for development."
Simon Meadows Smith
MANAGING DIRECTOR, SEMS EXPLORATION
"We believe technology should enhance, not replace, the role of geologists in exploration."
Shahram Tafazoli
FOUNDER AND CEO, MOTION METRICS
Motion Mertics explains how the latest technologies are being deployed in African mines.
Ricardo do Amaral
GENERAL MANAGER, OCTOMAR
Octomar explains how the company has navigated this difficult year and its plans to expand to partake in Mozambique’s exciting offshore developments.
Lorenzo Fiorillo
EVP WEST AFRICA, ENI
ENI updates GBR on the progress of its operations across Sub-Saharan Africa.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
